Cleveland Clinic millionaires, Mayo a better WebMD (Weekend Rounds)

Among the life science current events from last week: there are now 13 members of Cleveland Clinic who are paid at least $1 million annually, new thinking dictates that may be a better option than WebMD, a new roadmap for FDA devices, Israeli biomedical company’s expansion plans may benefit Ohio, and meet the future pharma rep.

A review of life science current events reported by MedCity News this week:

Cleveland Clinic Millionaires’ Club added 2 more members in 2009. Thirteen Cleveland Clinic employees were paid more than $1 million in 2009, two more than the prior year, according to the health system’s filings with the Internal Revenue Service. CEO Dr. Delos “Toby” Cosgrove was paid a little more than $2.1 million by the Clinic in 2009, about $500,000 more than any other Clinic employee listed in the document.

Mayo Clinic v. WebMD: Have standards suddenly changed? “New York Times columnist Virginia Heffernan suggests a new standard for online health information: that advice directly from reputable health systems beats third-party reporting coupled with a review, particularly when there is a greater financial motive behind the latter approach. ”

Radiology mobile app Mobile MIM’s long, strange FDA trip. It took nearly three years and three 510(k) applications, but MIM Software finally obtained FDA clearance for its Mobile MIM app, the first-ever radiology mobile app to receive the agency’s seal of approval. If there’s any good news for other radiology app developers, it’s that Beachwood, Ohio-based MIM’s experience might — might — provide a roadmap of sorts for the U.S. Food and Drug Administration to follow when the agency reviews similar mobile apps for devices like the iPhone and iPad in the future.

Cleveland-funded Israeli biomedical company raises $10M in IPO. An Israeli medical device company backed by a Northeast Ohio venture capital firm has raised more than $10 million in an initial public offering on the Tel Aviv Stock Exchange. Now the company, IceCure Ltd., is exploring whether to set up its U.S. sales and marketing headquarters in Northeast Ohio.

Pharmaceutical sales jobs will now require smart phones but little travel. Liz Cermak, executive vice president and chief commercial officer, says the Pozen (NASDAQ:POZN) pharma marketing force will be steeped in social media and they’ll target doctors who seek sales information through their mobile devices. It’s all part of the evolution of pharmaceutical marketing. The old way of pharmaceutical reps stopping by doctors’ offices during the business day won’t cut it in modern marketing and Cermak says the approach has diminishing results even now.